SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

Abstract	The authors and journal apologize for errors in the above paper, which appeared in volume 26 part 3, pages 303–319. The errors relate to the legend of Fig. 1A on page 307 and the artwork of Fig. 8D on page 316:
Authors	Fei Han, Wen-bin Liu, Jian-jun Li, Ming-qian Zhang, Jun-tang Yang, Xi Zhang, Xiang-lin Hao, Li Yin, Cheng-li Mao, Xiao Jiang, Jia Cao, Jin-yi Liu
Journal	Endocrine-related cancer (Endocr Relat Cancer) Vol. 27 Issue 2 Pg. X1-X2 (Feb 01 2020) ISSN: 1479-6821 [Electronic] England
PMID	31995343 (Publication Type: Journal Article)
Copyright	© 2020 Society for Endocrinology

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!